Innovation
4 September 2025In this eighth part of our innovator blog series, we spoke to Dr Jolynne Mokaya, Public Health Lead at the Wellcome Sanger Institute. With an entrepreneurial and ingenious spirit, Jolynne is helping to build a community of practice of cholera experts that will facilitate and progress research by leveraging regional expertise across several continents.
6 May 202512.9 min readWe spoke to Dr Trevor Lawley, Senior Group Leader at the Wellcome Sanger Institute who works in the Parasites and Microbes Programme. Trevor’s is the story of turning basic, fundamental research into innovative science with potential to treat a broad range of human diseases.
1 December 202413.3 min readBased originally upon the research of the human microbiome carried out at the Wellcome Sanger Institute, Microbiotica was spun out as a microbiome therapeutics company in 2016. Today, Microbiotica is advancing steadily towards introducing transformational microbiome-based therapeutics and biomarkers in areas of high medical need, with first clinical trials – underpinned by a landmark £50m investment during 2022 – starting soon.
2 August 20244.5 min readIn 2024, COSMIC – the world’s largest and most comprehensive resource on genetic mutations in cancer – celebrates two exciting milestones: COSMIC reaches its 20th anniversary and releases its 100th version of the database.
3 July 20248.8 min readThe HipSci cell lines, now searchable in a newer, user-friendly platform, are a resource used worldwide by researchers. They can be used for a wide variety of research applications, including large-scale experiments that require multiple cell lines created in a standardised manner.
11 June 20247.6 min readThe fourth edition of Sanger’s Startup School closed with 30 participants from the Wellcome Sanger Institute and EMBL-EBI having gained the confidence to look at science with a different, entrepreneurial perspective.
6 March 20248.9 min readMeet Valentina Migliori, a researcher working to make lab science more relevant to clinical research.
15 February 20249.1 min readWe spoke to Jyoti Nangalia, a researcher at the forefront of innovation in blood cancers. She is combining her clinical and academic expertise to bring better diagnosis tools for patients and clinicians.
